Preoperative management of anticoagulation and antiplatelet agents

Area of Science:

• Orthopedic Surgery
• Geriatric Medicine
• Pharmacology

Background:

• Hip fractures are common, particularly in elderly patients.
• Many patients with hip fractures are on anticoagulation or antiplatelet therapy for other medical conditions.
• Managing these medications perioperatively is crucial to balance the risk of bleeding and thromboembolic events.

Purpose of the Study:

• To review current literature on managing anticoagulation and antiplatelet agents in hip fracture patients.
• To discuss indications for these medications.
• To outline evidence-based management techniques for hip fracture patients on these therapies.

Main Methods:

• Literature review of current guidelines and studies.
• Analysis of indications for anticoagulation and antiplatelet therapy.
• Synthesis of management strategies for perioperative care.

Main Results:

• Anticoagulation and antiplatelet agents are frequently used in patients presenting with hip fractures.
• Management strategies vary based on the specific agent, indication, and surgical plan.
• Balancing bleeding risk and thrombotic risk is a key challenge.

Conclusions:

• Optimal management requires individualized treatment plans.
• Close collaboration between orthopedic surgeons, hematologists, and anesthesiologists is recommended.
• Further research is needed to refine best practices for anticoagulation and antiplatelet management in this population.